1-2 of 2
Udo Mueller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin, Lynley V. Marshall, Arnauld C. Verschuur, Adela Cañete Nieto, Nadège Corradini, Bart A. Ploeger, Barbara J. Brennan, Udo Mueller, Hong Zebger-Gong, John W. Chung, Birgit Geoerger
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (21): 4341–4351.
https://doi.org/10.1158/1078-0432.CCR-23-0257
Published: 01 November 2023
View article titled, Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Open the PDF for Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study in another window
Includes: Supplementary data
Journal Articles

Crossover Randomized Comparison of Intravenous versus Intravenous/Oral Mesna in Soft Tissue Sarcoma Treated with High-Dose Ifosfamide

Joseph R. Mace, Mary L. Keohan, Heinz Bernardy, Klaus Junge, Georg Niebch, Peter Romeis, Aangelika Thoma, Thomas Wagner, Udo Mueller, George Demetri, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5829–5834.
Published: 15 December 2003
View article titled, Crossover Randomized Comparison of Intravenous <em>versus</em> Intravenous/Oral Mesna in Soft Tissue Sarcoma Treated with High-Dose Ifosfamide
Open the PDF for Crossover Randomized Comparison of Intravenous <em>versus</em> Intravenous/Oral Mesna in Soft Tissue Sarcoma Treated with High-Dose Ifosfamide in another window